These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. New drugs for the treatment of non-Hodgkin lymphomas. Smith SM Chin Clin Oncol; 2015 Mar; 4(1):14. PubMed ID: 25841721 [TBL] [Abstract][Full Text] [Related]
54. Cell kinetics and cell cycle regulation in lymphomas. Leoncini L; Lazzi S; Bellan C; Tosi P J Clin Pathol; 2002 Sep; 55(9):648-55. PubMed ID: 12194992 [TBL] [Abstract][Full Text] [Related]
55. MT2 immunoreactivity, cellular proliferation and prognosis in B-cell non-Hodgkin's lymphoma. Hall PA; Gregory WM; Stansfeld AG Histopathology; 1989 May; 14(5):523-5. PubMed ID: 2737621 [No Abstract] [Full Text] [Related]
56. New active drugs in the treatment of lymphomas. Straneo M; Gianni L Curr Opin Oncol; 1994 Sep; 6(5):480-8. PubMed ID: 7827150 [TBL] [Abstract][Full Text] [Related]
58. Putting the clinical and biological heterogeneity of non-hodgkin lymphoma into context. O'Connor OA; Tobinai K Clin Cancer Res; 2014 Oct; 20(20):5173-81. PubMed ID: 25320367 [TBL] [Abstract][Full Text] [Related]